C. Russell Trenary III
2023
In 2023, C. Russell Trenary III earned a total compensation of $1.8M as President and Chief Executive Officer at Outlook Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,147,963 |
|---|---|
| Salary | $600,000 |
| Other | $10,899 |
| Total | $1,758,862 |
Trenary received $1.1M in option awards, accounting for 65% of the total pay in 2023.
Trenary also received $600K in salary and $10.9K in other compensation.
Rankings
In 2023, C. Russell Trenary III's compensation ranked 626th out of 2,918 executives tracked by ExecPay. In other words, Trenary earned more than 78.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 626 out of 2,918 | 79th |
Division Manufacturing | 352 out of 1,608 | 78th |
Major group Chemicals And Allied Products | 242 out of 901 | 73rd |
Industry group Drugs | 238 out of 864 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 80 out of 211 | 62nd |
Source: SEC filing on February 8, 2024.
Trenary's colleagues
We found two more compensation records of executives who worked with C. Russell Trenary III at Outlook Therapeutics in 2023.